Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Historical Holders from Q1 2023 to Q4 2025

Symbol
GPCR on Nasdaq
Type / Class
Equity / Ordinary Shares, $0.0001 par value
Shares outstanding
172,779,139
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
56,638,847
Holdings value
$1,582,549,935
% of all portfolios
0.01%
Number of holders
155
Number of buys
78
Number of sells
85
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 12% +20% $577,681,944 +$99,790,236 20,631,498 +21% Wellington Management Group LLP 31 Oct 2025
FMR LLC 12% $476,520,284 19,946,433 FMR LLC 30 Jun 2025
Avoro Capital Advisors LLC 9.4% $454,066,620 16,216,665 Avoro Capital Advisors LLC 30 Sep 2025
Deep Track Capital, LP 7.3% -18% $354,128,124 -$77,120,904 12,647,433 -18% Deep Track Capital, LP 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 5.6% $180,893,154 9,611,751 BVF PARTNERS L P/IL 11 Aug 2025
Capital Research Global Investors 3.8% $97,711,147 6,492,435 Capital Research Global Investors 31 Mar 2025
JANUS HENDERSON GROUP PLC 7.7% -3.8% $124,567,128 -$3,477,040 4,448,826 -2.7% JANUS HENDERSON GROUP PLC 30 Sep 2025
As of 30 Sep 2025 Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 56,638,847 shares of 172,779,139 outstanding shares and own 33% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) own 27% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
WELLINGTON MANAGEMENT GROUP LLP 3.3% 5,689,187 -17% 0.03% $159,297,236
FMR LLC 3% 5,250,368 +6.8% 0.01% $147,010,304
Avoro Capital Advisors LLC 3% 5,155,555 1.9% $144,355,540
JANUS HENDERSON GROUP PLC 2.6% 4,448,826 -2.7% 0.06% $124,603,170
Deep Track Capital, LP 2.4% 4,215,811 -18% 3.3% $118,042,708
BVF INC/IL 1.9% 3,203,917 +81% 3.6% $89,709,676
BAKER BROS. ADVISORS LP 0.9% 1,556,109 -38% 0.31% $43,571,052
Casdin Capital, LLC 0.9% 1,555,000 +27% 3.6% $43,540,000
RA CAPITAL MANAGEMENT, L.P. 0.88% 1,517,418 0% 0.52% $42,487,704
MILLENNIUM MANAGEMENT LLC 0.74% 1,274,551 +4.5% 0.03% $35,687,428
AMERIPRISE FINANCIAL INC 0.71% 1,224,144 -23% 0.01% $34,276,032
ORBIMED ADVISORS LLC 0.66% 1,139,300 -5% 0.77% $31,900,400
TCG Crossover Management, LLC 0.62% 1,063,000 0% 1.5% $29,764,000
Siren, L.L.C. 0.59% 1,026,811 1.1% $28,750,708
Rock Springs Capital Management LP 0.55% 951,154 -16% 1.6% $26,632,312
Driehaus Capital Management LLC 0.51% 873,504 +30% 0.18% $24,458,112
Logos Global Management LP 0.49% 850,000 0% 2.4% $23,800,000
PRINCIPAL FINANCIAL GROUP INC 0.46% 787,484 -7.7% 0.01% $22,049,552
FRANKLIN RESOURCES INC 0.43% 745,734 +0.53% 0.01% $20,880,551
Pacific Heights Asset Management LLC 0.41% 700,000 +52% 0.87% $19,600,000
Catalio Capital Management, LP 0.38% 651,810 -2.8% 3.4% $18,250,680
Aberdeen Group plc 0.34% 586,869 +46% 0.03% $16,432,332
MORGAN STANLEY 0.33% 577,741 -37% 0% $16,176,758
GOLDMAN SACHS GROUP INC 0.29% 504,396 +129% 0% $14,123,088
AMERICAN CENTURY COMPANIES INC 0.28% 486,786 -0.9% 0.01% $13,630,183

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 6,612 $459,865 +$402,973 $69.55 2
2025 Q3 56,638,847 $1,582,549,935 +$86,587,280 $28.00 155
2025 Q2 54,653,188 $1,133,630,623 -$12,998,790 $20.74 172
2025 Q1 55,933,663 $980,564,651 -$97,541,391 $17.31 150
2024 Q4 60,629,426 $1,644,598,756 -$124,823,773 $27.12 162
2024 Q3 61,353,441 $2,685,754,087 +$108,883,080 $43.89 162
2024 Q2 59,255,636 $2,326,748,042 +$608,455,583 $39.27 169
2024 Q1 43,607,567 $1,861,796,519 +$48,251,298 $42.86 127
2023 Q4 9,789 $399,000 -$3,125,680 $40.76 2
2023 Q3 32,752,287 $1,641,782,565 +$750,250,709 $50.42 83
2023 Q2 16,276,296 $676,606,969 +$71,646,929 $41.57 47
2023 Q1 14,412,457 $342,872,287 +$342,872,290 $23.79 39